McNeil Supplements Nutritionals Portfolio With Viactiv
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's Viactiv acquisition adds a popular calcium supplement to its nascent McNeil Nutritionals division of niche products.
You may also be interested in...
Johnson & Johnson President Brings Extensive McNeil Background To Post
Johnson & Johnson's appointment of James Lenehan, 53, as president signals a strong commitment by the company to its consumer products segments, despite the firm's shift in emphasis toward its pharmaceutical business over the past ten years
Mead Enfamil Sales Buoy Bristol-Myers Nutritionals In Q2
Increased spending on consumer ads and promos for Enfamil infant formula helped the brand post worldwide sales gains of roughly 8% to $172 mil. for the second quarter, Bristol-Myers Squibb's Mead Johnson division said July 25.
AHP Protonix OTC Switch Considered As Long-Term Possibility
American Home Products is interested in the Rx-to-OTC switch possibilities of its proton pump inhibitor Protonix but is unlikely to pursue nonprescription status for the drug in the near-term.